Investor alert: kirby mcinerney llp reminds investors that a securities class action lawsuit has been filed on behalf of revance therapeutics, inc. (rvnc) investors and encourages investors to contact the firm before february 8, 2022

New york--(business wire)---- $rvnc--the law firm of kirby mcinerney llp reminds investors that a class action lawsuit has been filed in the u.s. district court for the northern district of california on behalf of those who acquired revance therapeutics, inc. (“revance” or the “company”) (nasdaq: rvnc) securities from november 25, 2019 through october 11, 2021, inclusive (the “class period”). investors have until february 8, 2022 to apply to the court to be appointed as lead plaintiff in the lawsuit. rev
RVNC Ratings Summary
RVNC Quant Ranking